These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 38251485)
1. MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study. Hughes M; Di Donato S; Gjeloshi K; Abignano G; Danzo F; Lettieri G; De Lorenzis E; Bertham D; O'Connor P; Kubassova O; Dehmeshki J; Del Galdo F Lancet Rheumatol; 2023 Oct; 5(10):e611-e621. PubMed ID: 38251485 [TBL] [Abstract][Full Text] [Related]
2. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS). Bellando-Randone S; Del Galdo F; Lepri G; Minier T; Huscher D; Furst DE; Allanore Y; Distler O; Czirják L; Bruni C; Guiducci S; Avouac J; Cutolo M; Smith V; Matucci-Cerinic M; Lancet Rheumatol; 2021 Dec; 3(12):e834-e843. PubMed ID: 38287630 [TBL] [Abstract][Full Text] [Related]
3. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry. Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J; Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608 [TBL] [Abstract][Full Text] [Related]
4. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM; Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489 [TBL] [Abstract][Full Text] [Related]
5. Do We Have Good Activity Indices in Systemic Sclerosis? Groseanu L; Petrescu S; Balanescu A; Bojinca V; Opris-Belinski D; Berghea F; Mazilu D; Saulescu I; Borangiu A; Daia-Iliescu S; Constantinescu C; Cobilinschi C; Abobului M; Negru MM; Ionescu R Curr Rheumatol Rev; 2022; 18(1):39-47. PubMed ID: 34517805 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications. Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153 [TBL] [Abstract][Full Text] [Related]
7. Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications. Kumar U; Sankalp G; Sreenivas V; Kaur S; Misra D Rheumatol Int; 2013 Apr; 33(4):1047-52. PubMed ID: 22833239 [TBL] [Abstract][Full Text] [Related]
8. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers. Abou-Raya A; Abou-Raya S; Helmii M J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692 [TBL] [Abstract][Full Text] [Related]
9. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry. Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V; Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381 [TBL] [Abstract][Full Text] [Related]
10. Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Minier T; Guiducci S; Bellando-Randone S; Bruni C; Lepri G; Czirják L; Distler O; Walker UA; Fransen J; Allanore Y; Denton C; Cutolo M; Tyndall A; Müller-Ladner U; Matucci-Cerinic M; ; Ann Rheum Dis; 2014 Dec; 73(12):2087-93. PubMed ID: 23940211 [TBL] [Abstract][Full Text] [Related]
11. Digital ulcers predict a worse disease course in patients with systemic sclerosis. Mihai C; Landewé R; van der Heijde D; Walker UA; Constantin PI; Gherghe AM; Ionescu R; Rednic S; Allanore Y; Avouac J; Czirják L; Hachulla E; Riemekasten G; Cozzi F; Airò P; Cutolo M; Mueller-Ladner U; Matucci-Cerinic M; Ann Rheum Dis; 2016 Apr; 75(4):681-6. PubMed ID: 25688073 [TBL] [Abstract][Full Text] [Related]
12. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie). Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271 [TBL] [Abstract][Full Text] [Related]
13. The first composite score predicting Digital Ulcers in systemic sclerosis patients using Clinical data, Imaging and Patient history-CIP-DUS. Friedrich S; Lüders S; Klotsche J; Burmester GR; Riemekasten G; Ohrndorf S Arthritis Res Ther; 2020 Jun; 22(1):144. PubMed ID: 32539806 [TBL] [Abstract][Full Text] [Related]
14. Predictors of clinical features in early-onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort. Uesugi-Uchida S; Fujimoto M; Asano Y; Endo H; Goto D; Jinnin M; Kawaguchi Y; Tanaka S; Tokunaga T; Makino K; Matsushita T; Motegi SI; Yoshizaki A; Sato S; Hasegawa M J Dermatol; 2024 Oct; 51(10):1290-1297. PubMed ID: 39235167 [TBL] [Abstract][Full Text] [Related]
15. Is there a role for laser speckle contrast analysis (LASCA) in predicting the outcome of digital ulcers in patients with systemic sclerosis? Barsotti S; d'Ascanio A; Valentina V; Chiara S; Silvia B; Laura A; Mosca M; Della Rossa A Clin Rheumatol; 2020 Jan; 39(1):69-75. PubMed ID: 31317425 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire. Becker MO; Dobrota R; Garaiman A; Debelak R; Fligelstone K; Tyrrell Kennedy A; Roennow A; Allanore Y; Carreira PE; Czirják L; Denton CP; Hesselstrand R; Sandqvist G; Kowal-Bielecka O; Bruni C; Matucci-Cerinic M; Mihai C; Gheorghiu AM; Mueller-Ladner U; Sexton J; Kvien TK; Heiberg T; Distler O Ann Rheum Dis; 2022 Apr; 81(4):507-515. PubMed ID: 34824049 [TBL] [Abstract][Full Text] [Related]
17. Capillaroscopic findings in systemic sclerosis -- are they associated with disease duration and presence of digital ulcers? Lambova S; Müller-Ladner U Discov Med; 2011 Nov; 12(66):413-8. PubMed ID: 22127112 [TBL] [Abstract][Full Text] [Related]
18. Ulnar Artery Occlusion and Severity Markers of Vasculopathy in Systemic Sclerosis: A Multicenter Cross-Sectional Study. Lescoat A; Yelnik CM; Coiffier G; Wargny M; Lamotte C; Cazalets C; Belhomme N; Ballerie A; Hatron PY; Launay D; Perdriger A; Sobanski V; Hachulla E; Jégo P Arthritis Rheumatol; 2019 Jun; 71(6):983-990. PubMed ID: 30552835 [TBL] [Abstract][Full Text] [Related]
19. Vascular biomarkers and digital ulcerations in systemic sclerosis: results from a randomized controlled trial of oral treprostinil (DISTOL-1). Mecoli CA; Perin J; Van Eyk JE; Zhu J; Fu Q; Allmon AG; Rao Y; Zeger S; Wigley FM; Hummers LK; Shah AA Clin Rheumatol; 2020 Apr; 39(4):1199-1205. PubMed ID: 31858338 [TBL] [Abstract][Full Text] [Related]
20. Association between baseline clinical and imaging findings and the development of digital ulcers in patients with systemic sclerosis. Friedrich S; Lüders S; Glimm AM; Werner SG; Schmittat G; Burmester GR; Backhaus M; Riemekasten G; Ohrndorf S Arthritis Res Ther; 2019 Apr; 21(1):96. PubMed ID: 30987674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]